I guess we will see but without 'substantial' news like a partnership deal or the commencement of either the adult sr-GVHD trial or the CLBP trial I don't see the share price doing anything but continuing to slide
People claiming the FDA potency assay agreement / Remestemcel-L resubmission is 'close' need to understand it's not - even if Mesoblast received 'agreement' from the FDA and resubmitted this data today, it is my understanding that the FDA would still have circa 30 days to accept this resubmission and subsequently (at best) 60 additional days to make their decision .... that takes us (at the earliest) into the 2nd quarter of CY 2024 and that's if it was lodged today ?
GLTAH
banter and General Discussion, page-8464
-
- There are more pages in this discussion • 2,832 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |